Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2024 - Critical Care
Download Issue
Share
Up Front
Publisher's Corner
Innovative Therapies Continue to Advance Treatment Efficacy
By Patrick M. Schmidt
Features
Update on Molluscum Contagiosum
By
Jim Trageser
Why Bedside Manner Matters – and How to Make Yours Better
By
Rachel Maier, MS
The Proven Success of Immune Globulin Therapy to Treat Chronic Inflammatory Demyelinating Polyneuropathy
By
Lee Warren
Platelet-Rich Plasma Therapy: The Future of Healing?
By
Amy Scanlin, MS
The Future of Orphan Drugs: Advancements, Challenges and Hope
By
Trudie Mitschang
Myths & Facts: Plasma Donation
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
HHS Awards $45 Million in Grants to Expand Access to Care for People with Long COVID
Evidence-Based Teen Pregnancy Prevention Programs Receive HHS Awards
First Drugs Selected for Medicare Drug Price Negotiation
OCR Issues Resources to Educate Patients about Telehealth and the Privacy and Security of Protected Health Information
Reimbursement FAQs
Using Modifiers to Untangle Billing for Waste
Healthcare Management
Overcoming Challenges of Delivering Quality Healthcare
Industry News
FDA Expands Approval to wilate for Prophylaxis in All Types of VWDr
Cancer Drug Shows Promising Results in Clinical Trial
Study Shows Positive Results for mRNA-Based Combination Influenza and COVID-19 Vaccine
FDA Approves Vaccine for Meningococcal Disease in Adolescents
FDA Approves Celltrion’s Zymfentra to Treat Ulcerative Colitis and Crohn’s Disease
FDA Approves Wezlana, First Interchangeable Biosimilar to Stelara
BioFocus
Industry Insight
Coming Soon: Dried Plasma for Hemorrhagic Trauma in the Prehospital Setting
By Keith Berman, MPH, MBA
Patient Profile
Chronic Inflammatory Demyelinating Polyneuropathy: A Patient's Perspective
By Trudie Mitschang
Physician Profile
CIDP: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Hyaluronidase-Facilitated Subcutaneous Immune Globulin Effective as Maintenance Therapy for CIDP: Pivotal Trial Results
Outpatient Albumin Infusions Reduce Hospitalizations in Decompensated Cirrhosis: Retrospective Cohort Study